Global MMR Vaccine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global MMR Vaccine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

MMR vaccine is a vaccine against measles, mumps and rubella. The first dose is usually given to children from 9 months to 15 months old, and the second dose is given between 15 months and 6 years old, with at least 4 weeks between the two doses. After two doses, 97% of people can prevent measles, 88% can prevent mumps and at least 97% can prevent rubella. For those who have no proof of immunization, those who have good control of HIV/AIDS, and those who are not fully immunized, it is also recommended to take the vaccine within 72 hours after exposure to measles. It is administered by injection.

Market Overview:

The latest research study on the global MMR Vaccine market finds that the global MMR Vaccine market reached a value of USD 817.44 million in 2022. It’s expected that the market will achieve USD 985.77 million by 2028, exhibiting a CAGR of 3.17% during the forecast period.

In order to curb the COVID-19 epidemic, most countries have introduced many policies, including border blockade and social distancing. The epidemic prevention and control measures will affect the flow of people and activities, and in turn affect logistics, making the production of manufacturing, especially labor-intensive industries, affected by the supply of raw materials and labor shortages.

For the MMR Vaccine industry, the blockade policy will affect the supply of raw materials and export trade of products. The social distancing policy may have a great impact on the production of products, especially for some small factories, they will spend more money to maintain production during the epidemic, and factories may face the risk of closure in some areas. Under the influence of COVID-19 epidemic, the focus of medical researchers turned to Covid-19 vaccine. Some important medical resources are also invested in vaccine research in Covid-19, which will affect the progress of other medical research to a certain extent.

But in the long term, the COVID-19 outbreak may cause more factories to start using more automated production lines to avoid the pandemic's impact on the industry. In addition, the application of IoT technology may also bring more opportunities for industry participants.

Religious concerns

Measles infection occurs in unvaccinated individuals. There are many reasons why communities and individuals choose not to vaccinate, mainly due to religious and philosophical motives. Apart from the active ingredients (the antigens), MMR vaccines may contain very small amounts of these ingredients: highly purified gelatine derived from pigs, used as a stabilizer (MMRVaxPro only; the other MMR vaccine used in the UK, Priorix, does not contain gelatine); sorbitol or mannitol, used as stabilizers; polysorbate 80, used as an emulsifier (to hold other ingredients together); recombinant human serum albumin, used as a stabilizer (MMRVaxPro only). Religious objections usually focus on aborted human fetal tissues used in rubella component of combined vaccine products, and animal-derived gelatin used in vaccine production. Opposition between religious groups may not be based on faith, but in some cases, concerns related to the lack of safety and effectiveness of vaccination lead to rejection. Some brands of MMR Vaccine use gelatin from domestic pigs as stabilizer. This leads to a decrease in the number of patients and an increase in the disease level in communities with a high proportion of Muslim or Orthodox Jews. Religious issues may hinder the growth of MMR Vaccine industry demand.

Competition in the industry is fierce

For most industries the intensity of competitive rivalry is the major determinant of the competitiveness of the industry. Having an understanding of industry rivals is vital to successfully market a product. Positioning pertains to how the public perceives a product and distinguishes it from competitors. A business must be aware of its competitors marketing strategy and pricing and also be reactive to any changes made. The MMR Vaccine industry is facing a fierce competitive position. Many companies have been doing business in this industry. They pay more attention to R&D, product innovation, channel construction and customer relationship management, trying to gain greater market share and competitive advantage.

Region Overview:

In 2021, the share of the MMR Vaccine market in Asia Pacific stood at 55.39%.

Company Overview:

Merck & Co, GlaxoSmithKline, Serum Institute of India (SII), China National Biotec Group (CNBG) and Sanofi Pasteur are the five key players in the global MMR Vaccine market. These companies have shown consistent growth in revenue, larger volumes of sales and a prominent presence in terms of share in the global MMR Vaccine market in the past 5 years.

Merck & Co

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the worlds most challenging diseases. Through its prescription medicines, vaccines, biologic therapies and animal health products, Merck work with customers and operate in more than 140 countries to deliver innovative health solutions. Today, Merck continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimers disease and infectious diseases including HIV and Ebola.

GlaxoSmithKline

GlaxoSmithKline plc (GSK) is a British multinational pharmaceutical company headquartered in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham. GlaxoSmithKline have three global businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.

Segmentation Overview:

Among different product types, Pediatric segment is anticipated to contribute the largest market share in 2027.

Application Overview:

The market's largest segment by application is the segment Hospitals Pharmacies, with a market share of 52.67% in 2021.

Hospitals Pharmacies

Hospital pharmacy is a kind of pharmacy in hospital, which is used to prepare, compound, store and distribute inpatient drugs. Hospital pharmacies usually store a wider range of drugs than are feasible in the community environment, including more specialized and research drugs. Hospital pharmacies can also distribute over-the-counter and prescription drugs to outpatients. Hospital pharmacies may provide a large number of drugs every day, which are distributed to wards and intensive care units according to the patient's medication schedule.

Pharmacies & Drug Stores

Pharmacies & Drug Stores provides pharmaceutical drugs, among other products. At the pharmacy, a pharmacist oversees the fulfillment of medical prescriptions and is available to counsel patients about prescription and over-the-counter drugs or about healthcare and wellness issues.

Family Medical Clinic

Family Medicine Clinics are multi-doctor practice supported by a team of nurses and allied health professionals to provide holistic primary care services.

Key Companies in the global MMR Vaccine market covered in Chapter 3:

GlaxoSmithKline
Serum Institute of India (SII)
China National Biotec Group (CNBG)
Sanofi Pasteur
Bio-Manguinhos/Fiocruz
Merck & Co

In Chapter 4 and Chapter 14.2, on the basis of types, the MMR Vaccine market from 2018 to 2029 is primarily split into:

Pediatric
Adult

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the MMR Vaccine market from 2018 to 2029 covers:

Hospitals Pharmacies
Pharmacies & Drug Stores
Family Medical Clinic
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)